Dr. Cheng Qianyi is responsible for patent search analysis, risk assessment, and intellectual property due diligence related to the project development process of the group and its subsidiaries. Responsible for IP management of small molecule innovative drugs and multiple ADC drug projects. Apply for patents, layout and plan according to project progress. Based on sufficient monitoring and research of competitors, form effective patent layout, IP management, and risk control. Participate in the internationalization of the company's products and carry out FTO work in Europe and America. Participate in ineffective and intellectual property management, training, and other related work.

I have worked in the Chemistry Department of the Beijing Center for Patent Examination Cooperation of the National Patent Office for nearly ten years, and have completed over 700 substantive examination cases involving chemical, pharmaceutical, and other fields. My main areas of expertise include small molecule drugs and organic synthesis methods, pesticides, dyes, chemical processes, etc. I have extensive experience in searching and examining patent applications in fields such as organic small molecule compounds, Markush compounds, crystals, compound synthesis methods, natural product extraction, and organic synthesis methods and processes. Have experience in part-time re examination, preliminary examination, as well as PCT international search and preliminary examination. Participated in multiple enterprise service projects, involving FTO, patentability analysis, invalid analysis opinions, etc.